Top Stories
-
New protein points to possible Alzheimer’s cure
Discovery indicates potential for new drugs that suppress beta amyloid without affecting other functions -
Halcygen reports maiden profit
Acquisition of Mayne Pharma a major factor in reversing the previous year’s loss -
Feature: Diagnosing Darwin
For much of his life, Charles Darwin lived with a mysterious illness that caused bouts of intense nausea and vomiting. Now Melbourne pathologist, Dr John Hayman, has a theory as to the cause of this strange disorder. -
Bionomics anxiety drug could be more effective than valium
Study results show BNC210 more effective in treating stressed rats with Phase Ib trials scheduled for later this year -
Market report: Healthcare index outperforms wider market
Local biotechs post strong week despite global economic concerns -
China and India pharma companies driving M&A activity in Asia
Strong growth of Asian middle class driving local activity as well as attracting more foreign investment
Biotech
- New protein points to possible Alzheimer’s cure
- Halcygen reports maiden profit
- Bionomics anxiety drug could be more effective than valium
- Market report: Healthcare index outperforms wider market
- China and India pharma companies driving M&A activity in Asia
- Ramsay reports strong FY profit jump
- Argy-bargy continues at Avexa
- Under-arm license delivers maiden FY profit for Acrux
- Mesoblast FY results reveal more red ink
- Clinuvel identifies potential new target for Scenesse
Biomedical
- Bionomics anxiety drug could be more effective than valium
- Argy-bargy continues at Avexa
- Under-arm license delivers maiden FY profit for Acrux
- Mesoblast FY results reveal more red ink
- Clinuvel identifies potential new target for Scenesse
- Mesoblast to buy US partner Angioblast
- Professor Philip Hogg wins lead Eureka prize
- Specialised Therapeutics announces success of compassionate cancer program
- Monash University professor receives GSK Australia Award for Research
- Aspen to buy Sigma Pharmaceuticals' drug division for $900m
Bioinformatics
- Bionomics anxiety drug could be more effective than valium
- Feature: Next next generation sequencing
- Clinuvel identifies potential new target for Scenesse
- Feature: Automating the personalised medicine revolution
- Want a career in science? Good at maths? Bioinformatics needs you!
- Illumina Genome Network launches for human genome sequencing community
- Biota Holdings targeting asthma market with anti-viral drug
- Feature: Towards the $1000 genome
- Feature: How next generation sequencing could save the Tasmanian devil
- Nanotech lets doctors camera see cancer cells
QSR International eyes new markets as it appoints new VP, Global Sales 2010-08-06 14:28:32
The MCG goes digital 2010-07-26 10:34:29
As good as an atomic clock 2010-07-07 11:56:29
Symantec Introduces Archiving and eDiscovery Specialisation for Partners 2010-07-01 10:17:23
RIM Announces Initiatives to Support Innovation in the Australian Mobile Industry 2010-06-08 11:12:05
Biotechnology Directory Company Profile
Biotechnology Directory
Good Gear Guide
Computerworld
CIO
ARN

